0001104659-22-128766.txt : 20221220
0001104659-22-128766.hdr.sgml : 20221220
20221220200050
ACCESSION NUMBER: 0001104659-22-128766
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221216
FILED AS OF DATE: 20221220
DATE AS OF CHANGE: 20221220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bernstein Bruce
CENTRAL INDEX KEY: 0001665472
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40458
FILM NUMBER: 221476299
MAIL ADDRESS:
STREET 1: 780 THIRD AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Synaptogenix, Inc.
CENTRAL INDEX KEY: 0001571934
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461585656
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 9732420005
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: NEUROTROPE BIOSCIENCE, INC.
DATE OF NAME CHANGE: 20130312
4
1
tm2233089-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-12-16
0
0001571934
Synaptogenix, Inc.
SNPX
0001665472
Bernstein Bruce
C/O SYNAPTOGENIX, INC., 1185 AVENUE
OF THE AMERICAS, 3RD FLOOR
NEW YORK
NY
10036
1
0
0
0
Common Stock, par value $0.0001 per share
2022-12-16
4
S
0
22500
1.1719
D
27578
D
Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
/s/ Robert Weinstein, Attorney-in-fact
2022-12-20